Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Megan A Smith

Showing results (41-50 of 92) with videos related to

Pageof 10
Sort By:
The Lancet. Public Health|February 6, 2026
Accelerating cervical cancer elimination in Aboriginal and Torres Strait Islander women: a modelling studyMegan A Smith, James Killen, Lisa Jamieson, et al.
Gynecologic Oncology|January 31, 2021
Active surveillance as a management option for cervical intraepithelial neoplasia 2: An online experimental studyRachael H Dodd, Erin Cvejic, Katy Bell, et al.
Plos One|March 9, 2026
Experiences of HPV self-collection among Aboriginal and Torres Strait Islander women and people with a cervixLouise E Mitchell, Emily Phillips, Chloe J Jennett, et al.
Plos Medicine|March 11, 2021
Human papillomavirus vaccination for adults aged 30 to 45 years in the United States: A cost-effectiveness analysisJane J Kim, Kate T Simms, James Killen, et al.
Plos One|January 18, 2017
Optimal Management Strategies for Primary HPV Testing for Cervical Screening: Cost-Effectiveness Evaluation for the National Cervical Screening Program in AustraliaKate T Simms, Michaela Hall, Megan A Smith, et al.
Gynecologic Oncology|December 2, 2025
Optimising management of women with HPV (not 16/18): Findings from a national HPV screening programMonjura Nisha, Ya-Lun Liang, Deborah Bateson, et al.
Vaccine|December 16, 2018
Age-specific HPV prevalence among 116,052 women in Australia's renewed cervical screening program: A new tool for monitoring vaccine impactJulia Ml Brotherton, David Hawkes, Farhana Sultana, et al.
The Lancet. Public Health|October 7, 2018
The projected timeframe until cervical cancer elimination in Australia: a modelling studyMichaela T Hall, Kate T Simms, Jie-Bin Lew, et al.
The Lancet. Oncology|February 24, 2019
Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99: a modelling studyKate T Simms, Julia Steinberg, Michael Caruana, et al.
Vaccine|March 16, 2025
Predicted impact of HPV vaccination and primary HPV screening on precancer treatment rates and adverse pregnancy outcomes in Australia 2010-2070: Modelling in a high income, high vaccination coverage country with HPV-based cervical screeningSusan Yuill, Michaela T Hall, Michael Caruana, et al.
Pageof 10

Showing results (41-50 of 92) with videos related to

Sort By:
Pageof 10
The Lancet. Public Health|February 6, 2026
Accelerating cervical cancer elimination in Aboriginal and Torres Strait Islander women: a modelling studyMegan A Smith, James Killen, Lisa Jamieson, et al.
Gynecologic Oncology|January 31, 2021
Active surveillance as a management option for cervical intraepithelial neoplasia 2: An online experimental studyRachael H Dodd, Erin Cvejic, Katy Bell, et al.
Plos One|March 9, 2026
Experiences of HPV self-collection among Aboriginal and Torres Strait Islander women and people with a cervixLouise E Mitchell, Emily Phillips, Chloe J Jennett, et al.
Plos Medicine|March 11, 2021
Human papillomavirus vaccination for adults aged 30 to 45 years in the United States: A cost-effectiveness analysisJane J Kim, Kate T Simms, James Killen, et al.
Plos One|January 18, 2017
Optimal Management Strategies for Primary HPV Testing for Cervical Screening: Cost-Effectiveness Evaluation for the National Cervical Screening Program in AustraliaKate T Simms, Michaela Hall, Megan A Smith, et al.
Gynecologic Oncology|December 2, 2025
Optimising management of women with HPV (not 16/18): Findings from a national HPV screening programMonjura Nisha, Ya-Lun Liang, Deborah Bateson, et al.
Vaccine|December 16, 2018
Age-specific HPV prevalence among 116,052 women in Australia's renewed cervical screening program: A new tool for monitoring vaccine impactJulia Ml Brotherton, David Hawkes, Farhana Sultana, et al.
The Lancet. Public Health|October 7, 2018
The projected timeframe until cervical cancer elimination in Australia: a modelling studyMichaela T Hall, Kate T Simms, Jie-Bin Lew, et al.
The Lancet. Oncology|February 24, 2019
Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99: a modelling studyKate T Simms, Julia Steinberg, Michael Caruana, et al.
Vaccine|March 16, 2025
Predicted impact of HPV vaccination and primary HPV screening on precancer treatment rates and adverse pregnancy outcomes in Australia 2010-2070: Modelling in a high income, high vaccination coverage country with HPV-based cervical screeningSusan Yuill, Michaela T Hall, Michael Caruana, et al.
Pageof 10